OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Titanium Dioxide 4.4%, Zinc Oxide 5.5%
Drug Facts
- Manufacturer
- Allure Labs, Inc.
- Effective date
- 2011-02-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 22:27:22
Label at a glance#
ProductDermaQuest TM Skin Therapy, Breathable Coverage TM Mineral Foundation SPF-30, DermaMinerals TM
Active ingredientTITANIUM DIOXIDE, ZINC OXIDE
Label structure3 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Cyclopentasiloxane , Dimethicone, Dimethicone PEG-10/15 Crosspolymer, Water(Aqua), Vinyl Dimethicone Crosspolymer, Cyclomethicone, PEG/PPG-18/18 Dimethicone, Perfluorodecalin, Hydrolyzed Ceratonai Siliqua Seed Extract, Phopspholipids, Saccgaromyces Lysate Extract, Sodium PCA, PPG-12/SMDI Copolymer, Magnesium Silicate, Nylon-12, Tocopheryl Acetate, Santalum Album (Sandalwood) Extract, Phellodendron Amurense Bark Extract, Hordeum Distichon (Barley ) Extract, Sodium Hyaluronate, Saccaromyces, Xylinium Black Tea Ferment, Glycerin, Hydroxyethylcellulose, Algae Extract, Artemesia Vulgaris Extract, Centella Asiatica Extract, Cetearyl Olivate, Sorbitan Olivate, Tetrahxyldecyl Ascorbate, Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone, Hexyl Triethoxysilylethyl Polydimethylsiloxyethyl Dimethicone, Stearic Acid, Aluminum Hydroxide, Polyglyceryl-4 Isostearate, Cetyl PEG/PPG-10/1 Dimethicone, Hexyl laurate, Phenoxyethanol, Caprylyl Glycol, Ethylhexylglycerin, Hexylene Glycol, Aloe Barbedensis Leaf Juice Powder.
[+/- (May Contain) Iron Oxides (Cl77499, Cl 77491, Cl77492), Titanium Dioxide (Cl 77891)]
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DIRECTIONS:
Apply with a foundation brush for flawless coverage. Discontinue use if irritation develops.
Protect from harmful UVA and UVB rays while creating the perfect canvas with our mineral-based SPF 30 liquid foundation.
Paraben-Free
Talc-Free
SyntheticDye-Free
Bismuth Oxychloride-Free
Oil-Free
Very WaterResistant
Manufactured for DermaQuest TM, Inc.
Hayward
CA, 94544
dermaquestinc.com
Made in USA
PRINCIPAL DISPLAY PANEL:
DERMAQUEST SKIN THERAPY
Breathable Coverage
Mineral Foundation SPF30
DermaMinerals TM
1 Fl Oz / 29.6 mL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62742-4030-2 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d49c-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62742-4030-1 | DermaQuest TM Skin Therapy, Breathable Coverage TM Mineral Foundation SPF-30, DermaMinerals TM | 30 mL in 1 TUBE | CREAM | 30 | 4 | |
| 62742-4030-2 | DermaQuest TM Skin Therapy, Breathable Coverage TM Mineral Foundation SPF-30, DermaMinerals TM | 1 in 1 CARTON | CREAM | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62742-4030 | DERMAQUEST TM SKIN THERAPY, BREATHABLE COVERAGE TM MINERAL FOUNDATION SPF-30, DERMAMINERALS TM (ZINC OXIDE AND TITANIUM DIOXIDE ) CREAM [ALLURE LABS, INC. ] | 4 | Legacy NDC, 2 package rows | 20110304_3d7c72b7-35e1-4029-9e1a-758743e23573.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 4 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 4 | |
| Titanium | ACTIVE MOIETY | D1JT611TNE | 4 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 4 | |
| .ALPHA.-TOCOPHEROL ACETATE, D- | INACTIVE INGREDIENT | A7E6112E4N | 4 | |
| Aluminum Hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 4 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 4 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 4 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| Hexyl Laurate | INACTIVE INGREDIENT | 4CG9F9W01Q | 4 | |
| Hexylene Glycol | INACTIVE INGREDIENT | KEH0A3F75J | 4 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 4 | |
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | INACTIVE INGREDIENT | S38J6RZN16 | 4 | |
| MAGNESIUM TRISILICATE | INACTIVE INGREDIENT | C2E1CI501T | 4 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 4 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 4 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Products#
Every source-derived product name is available through these pages.
- DermaQuest TM Skin Therapy, Breathable Coverage TM Mineral Foundation SPF-30, DermaMinerals TM
- Zinc Oxide and Titanium Dioxide
- TITANIUM DIOXIDE
- Titanium
- ZINC OXIDE
- ZINC CATION
- Dimethicone
- Water
- Cyclomethicone
- HYALURONATE SODIUM
- HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)
- Stearic Acid
- Aluminum Hydroxide
- Hexyl Laurate
- Phenoxyethanol
- Hexylene Glycol
- GLYCERIN
- CYCLOMETHICONE 5
- SODIUM PYRROLIDONE CARBOXYLATE
- MAGNESIUM TRISILICATE
- .ALPHA.-TOCOPHEROL ACETATE, D-
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62742-4030 | 62742-4030-1, 62742-4030-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | TABLET, CHEWABLE / ORAL | 5.9 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Aluminum Hydroxide | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | TABLET / ORAL | 50 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| MAGNESIUM TRISILICATE | MAGNESIUM TRISILICATE | C2E1CI501T | TABLET, DELAYED RELEASE / ORAL | 120 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| Hexylene Glycol | HEXYLENE GLYCOL | KEH0A3F75J | GEL / TOPICAL | 280 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| Hexylene Glycol | HEXYLENE GLYCOL | KEH0A3F75J | SOLUTION / TOPICAL | 0.3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SUSPENSION / OPHTHALMIC | 0.25 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | POWDER, FOR SUSPENSION / ORAL | 560 mg | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SUSPENSION / AURICULAR (OTIC) | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | LOTION / TOPICAL | 0.2 %w/v | ||
| HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) | HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | S38J6RZN16 | SOLUTION / ORAL | 3 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 04dd129a-7c7b-42a0-8803-dbdda59396de | 3d7c72b7-35e1-4029-9e1a-758743e23573 | 2011-02-23 | 04dd129a-7c7b-42a0-8803-dbdda59396de 3d7c72b7-35e1-4029-9e1a-758743e23573 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.